Question

Please state the category of risk for the study below and justify your answer.Categories: Minimal risk, greater than minimal risk, moderate risk, high risk DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial ancRenal Cell CancersSummary:This phase Ib trial studies the side effects and best dose of DS8201 when given together with and ipilimumab for the treatment of patients with prostate, urothella or renal cell cancer that has spread to other places in the body (metastatic). DS320 may stop the growth of tumor cells by blocking some of the enzymes needed for c growth. Immunotherapy with monocional antibodies, such as ipilimumab, may help the body's immune system attack the cancer, and may infecterg with the ability of tumor cells to grow and spread. Sting B63201 and ipilinumab may help te contral the diseaseDS3201 is an orally available potent and selective inhibitor of EZH1 and EZH2 (th histone lysine methyltransferases enhancer of zeste homolog 1 and 2) (both wild-type and mutated forms) with IC50s in nanomolar concentrationsIpilimumab is an IV infusion monocional antibody that works to activate the immu system by targeting CTLA-4, a protein receptor that downregulates the immune system

Name: please state the category of risk for the study below and justify your answercategories minimal risk greater than minimal risk moderate risk high risk ds3201 and ipilimumab for the treatment 47004
Uploaded: 2026-05-14T11:00:04-08:00
Duration: 1 min 40 s
Channel: Numerade
Description: please state the category of risk for the study below and justify your answercategories minimal risk greater than minimal risk moderate risk high risk ds3201 and ipilimumab for the treatment 47004

          Please state the category of risk for the study below and justify your answer.Categories: Minimal risk, greater than minimal risk, moderate risk, high risk DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial ancRenal Cell CancersSummary:This phase Ib trial studies the side effects and best dose of DS8201 when given together with and ipilimumab for the treatment of patients with prostate, urothella or renal cell cancer that has spread to other places in the body (metastatic). DS320 may stop the growth of tumor cells by blocking some of the enzymes needed for c growth. Immunotherapy with monocional antibodies, such as ipilimumab, may help the body's immune system attack the cancer, and may infecterg with the ability of tumor cells to grow and spread. Sting B63201 and ipilinumab may help te contral the diseaseDS3201 is an orally available potent and selective inhibitor of EZH1 and EZH2 (th histone lysine methyltransferases enhancer of zeste homolog 1 and 2) (both wild-type and mutated forms) with IC50s in nanomolar concentrationsIpilimumab is an IV infusion monocional antibody that works to activate the immu system by targeting CTLA-4, a protein receptor that downregulates the immune system

Added by Kristen G.

Question

Please give Ace some feedback